← Back to Browse

EFTA01268401.pdf

set10 Interestingness: 6/10 Original PDF ↗

AI Summary

Email correspondence from October 2017 regarding cost basis calculations for securities transfers including stocks in Ascena Retail Group, Foundation Medicine, and Sangamo Therapeutics worth over $3 million total. The document appears to be part of financial record keeping related to asset transfers. [Rating: 6/10 - Document shows substantial financial transactions totaling over $3 million in securities transfers with specific cost basis details, indicating significant asset management activity]

Flags

financial_transactions

Extracted Entities

Name Type Context
Ascena Retail Group Inc. organization Publicly traded company with 70,500 shares transferred valued at $1.5 million
Foundation Medicine Inc organization Publicly traded company with 49,830 shares transferred valued at $1.265 million
HBRK Associates Inc. organization Richard Kahn's company located at 575 Lexington Avenue, New York
Sangamo Therapeutics Inc organization Publicly traded company with 50,000 shares transferred valued at $422,214
Paul Barrett person CC'd on email correspondence about cost basis
Rafael C Otoya person Recipient of email requesting cost basis information
Richard Kahn person Financial professional at HBRK Associates providing cost basis information for transferred securities

Full Text

From:
To:
Subject: RE: Cost Basis
Date: Tuesday. October 10. 2017 2:26:08 PM
OK... That's what they reported to us. Let me know if there's anything else I can support
you with.
From: Richard Kahn [mailto
Sent: Tuesday, October 10, 2017 1:17 PM
To: Otoya, Rafael C
Cc: Paul Barrett
Subject: Re: Cost Basis
Cost basis of securities transferred in are as follows:
Thank you
Purchase Quantity
Asset Description Date Cost
Ascena Retail Group Inc. (Formerly Dress
1/16/01 70,500 1,500,000
Barn 1.3.11)
Foundation Medicine Inc 1/16/14 49,830 1,265,037
Sangamo Therapeutics Inc 5/28/13 50,000 422,214
Richard Kahn
HBRK Associates Inc.
575 Lexington Avenue, 4th Floor
New York, NY 10022
On Oct 10, 2017, at 2:09 PM, <
wrote:
CONFIDENTIAL SDNY_GM_00012330
EFTA_00 122979
EFTA01268401

Hello, Richard. I wanted to follow up with you. My understanding is that there
may be some questions around cost basis for the assets that you transferred
over. How may I support you?
<image003.jpg>
CONFIDENTIAL SDNY_GM_00012331
EFTA_00 122980
EFTA01268402